RESPONSE TO DRS. HERTZMAN AND ZEEBERG
The issue of nonspecific tissue binding and the appropriate assessment of specific neuroreceptor binding parameters in vivo is raised by Hertzman and Zeeberg. The point they raise is both semantic and substantive. The semantic issue is whether the rate constants ks and k6' representing "slow" mea surable tissue binding for (S ,S)-3-quinuclidinyl 4-e 2s I]iodobenzilate [(S,S)-IQNB], actually de scribe a truly "nonspecific" binding process (Sawada et aI., 1990) or whether these rate con stants should be redefined in terms of a low-affinity, specific receptor binding process (e .g., redefined as rate constants k3 and k4 using their nomenclature).
Hertzman and Zeeberg are correct in raising this point since the appropriate in vivo studies were not performed; administration of muscarinic acetylcho line receptor (mAchR) saturation doses of (R,R) IQNB to determine whether (S,S)IQNB binding is non saturable and therefore nonspecific in brain could not be performed owing to the in vivo toxicity of (R,R)-IQNB. Recent in vitro studies using a membrane fraction from rat parietal cortex have demonstrated that the Kd of (S,S)-IQNB is 170 times greater than that of (R,R)-IQNB and that the Bmax estimate with (S,S)-IQNB is one-fourth that obtained with (R,R)-IQNB (Y. Hiramatsu et aI., un published observations). Assuming that a single sat urable site is identified by both ligands (which may not be the case), the in vitro binding potential (B ma) Kd) differential between (R,R)-IQNB and (S,S) IQNB calculates to be >600. If these results are transferable to the in vivo experiments, saturable low-affinity binding of (S,S)-IQNB is indeed small compared with saturable high-affinity binding of (R,R)-IQNB. Nevertheless, we stated in Sawada et ai. (1990) that "the rank order of kslk6 values for the tissues examined in this study correspond to the relative concentrations of mAChRs in these struc tures (Cortes and Palacios, 1986) and supports this latter hypothesis."
There are two substantive issues that Hertzman and Zeeberg do not address in their letter and sim ulations. First, the model used by Hertzman and Zeeberg does not allow for time-dependent nonspe cific tissue binding, which has been shown for other neuroreceptor ligands such as carfentanil (Frost et aI., 1989 ) and (+ )-cyclofoxy (Kawai et aI., 1990) . Second, a major point of our article was to illustrate that various models can give equally good fits of the data. In the analysis of Hertzman and Zeeberg, "the simulated concentration of free ligand in tissue implicitly includes nonspecific tissue localization" ; namely, rapid ("instantaneous" ) nonspecific tissue binding is assumed and is included in the k2 term. Thus, Hertzman and Zeeberg's three-compartment, four-parameter model is equivalent to our models 2 and 6 for (S,S)-and (R,R)-IQNB, respectively (Fig.  1, Sawada et aI., 1990) . Since the estimated K)lk2 ratios are substantially different for (S,S)-and (R,R)-IQNB using this model (0.071 ± 0.033 and 0 .203 ± 0.078 ml/g tissue, respectively; Sawada et aI., 1990) , comparisons between kslk6 and k31k4 for the two enantiomers are not strictly valid.
Apparent inconsistencies can result from a ki netic (curve-fitting) analysis of the data when the fitted parameters (rate constants) of the model are assigned specific physiologic or pharmacologic meaning. We demonstrate in Sawada et al. (1990) that certain physiological constraints are advanta geous in the kinetic analysis of in vivo receptor ligand binding data. For example, by constraining the K / k2 ratio in terms of the volume of distribution of the free ligand, one can estimate the equilibrium constant for rapid (instantaneous) nonspecific bind ing (Keq) and directly compare values such as k51k6 or Keq and k31k4' This constraint (K1lk2 = fb . X-w) is based on the measured free fraction of ligand in blood ifb) and the tissue-to-blood water partition co efficient (X-w) (Sawada et aI., 1990) . This constraint also permits the calculation of the "free" ligand concentration (Cf) in tissue water: Cf = Cbifb . X-w), where Cb is the measured concentration of ligand in blood under near-equilibrium conditions.
Hertzman and Zeeberg's simulations illustrate an important point with respect to the use of "inactive" enantiomers for the measurement of nonspecific tissue binding. This point was clearly demonstrated by our experiments with cyclofoxy in which simultaneous measurements of receptor binding [( -)-cyclofoxy] and receptor-inert [( +) cyclofoxy] enantiomers were performed (Kawai et aI., 1991) . In brain regions with low receptor con centrations [or measurements under near-saturation conditions], small errors in measurement or small differences in nonspecific tissue binding between the structure of interest and the reference region can produce sizable errors in estimates of B ma x and Kd• When specific receptor binding is small relative to nonspecific binding, issues of accuracy and ap propriateness of the measurements assume greater importance. The question of whether in vivo bind ing of (S,S)-IQNB to mAChRs occurs with low af finity and in a saturable manner cannot be answered with certainty from an analysis of the data pre sented in Sawada et ai. (1990) ; the k51k6 ratio ob-
